Physician profile
Brian Safier
NPI 1083878607
$1,050.93
in general payments reported to CMS, 2019-2025
16 companies · $340 in 2025
The $340 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $120 · 2023: $23.39 · 2024: $145 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $288.98 | 2019-2025 | Nucala |
| Optinose US, INC. | $205.77 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $109.80 | 2019-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $109.30 | 2019-2025 | Fasenra, Airsupra |
| Genzyme Corporation | $47.18 | 2020-2025 | |
| Kaleo, INC. | $38.06 | 2019-2020 | |
| Acclarent, INC | $37.99 | 2019 | |
| Inspire Medical Systems, INC. | $35.34 | 2025 | Inspire |
| Medtronic USA, INC. | $29.44 | 2019 | |
| Novartis Pharmaceuticals Corporation | $27.00 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $25.43 | 2025 | Neffy |
| Stryker Corporation | $25.36 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.00 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $19.75 | 2019 | |
| Amgen INC. | $16.10 | 2025 | Tezspire |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Safier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.